Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18.

被引：0
|
作者：
Leighl, NB
Shepherd, F
Paz-Ares, L
Douillard, JY
Peschel, C
Arnold, A
Tu, D
Galbraith, S
Hann, K
Seymour, L
机构：
[1] Natl Canc Inst Canada, Kingston, ON, Canada
[2] Bristol Myers Squibb, Wallingford, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7038
引用
收藏
页码：626S / 626S
页数：1
相关论文
共 50 条
  • [41] Phase II study of paclitaxel (Genaxol®) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)
    Chen, CH
    Chang, WC
    Lin, MC
    Hsu, JW
    Chao, TY
    Tsao, TCY
    LUNG CANCER, 2002, 38 (01) : 91 - 96
  • [42] A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Blumenschein, G
    Ludwig, C
    Thomas, G
    Tan, E
    Fanucchi, M
    Santoro, A
    Crawford, J
    Breton, J
    O'Brien, M
    Khuri, F
    LUNG CANCER, 2005, 49 : S30 - S30
  • [43] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, PA
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 621S - 621S
  • [44] A phase IB trial of iniparib (BSI-201) in combination with carboplatin (C)/paclitaxel (P) in patients with non-small cell lung cancer (NSCLC).
    Mita, A. C.
    Mita, M. M.
    Rocha, C.
    Bradley, C. R.
    Sarantopoulos, J.
    O'Rourke, P.
    Gadgeel, S. M.
    Wozniak, A. J.
    Heath, E. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
    Kosmidis, P
    Kalofonos, C
    Syrigos, K
    Skarlos, D
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Samantas, E
    Bakogiannis, C
    Dimopoulos, A
    LUNG CANCER, 2005, 49 : S34 - S34
  • [46] Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLC)
    Hirsh, V.
    Boyer, M.
    Rosell, R.
    Benner, R. J.
    Readett, D.
    Schiller, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Randomized phase 2 study of efatutazone in combination with carboplatin and paclitaxel as first-line therapy for metastatic non-small cell lung cancer (NSCLC)
    Shaw, Alice T.
    Ghizdavescu, Doru
    Jain, Minish
    Volovat, Constantin
    Subramaniam, Deepa
    Shuster, Dale
    Jin, Xiaoping
    Dutta, Dipen
    Pai, Seema
    von Roemeling, Reinhard
    CANCER RESEARCH, 2012, 72
  • [48] Proto-adjuvant chemotherapy with paclitaxel (P), carboplatin (C) and gemcitabine (G) in locally advanced inoperable non-small cell lung cancer (NSCLC).: A phase II study.
    Schallier, D
    Neyns, B
    Fontaine, C
    de Mey, J
    Meysman, M
    van de Steene, J
    de Grève, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 691S - 691S
  • [49] A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Allerton, J. P.
    Hagenstad, C. T.
    Webb, R. T.
    Smith, G. B.
    Birch, R.
    Goggins, T. F.
    Katakkar, S. B.
    Khan, W.
    Mehta, N. D.
    Greco, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 395S - 395S
  • [50] PHASE II RANDOMIZED, OPEN-LABEL STUDY OF CETUXIMAB (CET) AND BEVACIZUMAB (BEV) IN COMBINATION WITH PACLITAXEL (P) AND CARBOPLATIN (C) IN PATIENTS WITH STAGE IIIB/IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Bonomi, Philip
    Mace, Joseph
    Mandana, Romeo
    Min, Myo
    Mark, Olsen
    Youssoufian, Hagop
    Katz, Terry
    Simms, Lorinda
    Lee, Hyun Jung
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1292 - S1292
12345